Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zeal Kamdar"'
Autor:
Donald Long, Jr., Marina Chan, Mingqi Han, Zeal Kamdar, Rosanna K. Ma, Pei-Yin Tsai, Adam B. Francisco, Joeva Barrow, David B. Shackelford, Mark Yarchoan, Matthew J. McBride, Lukas M. Orre, Nathaniel M. Vacanti, Taranjit S. Gujral, Praveen Sethupathy
Publikováno v:
Cell Reports Medicine, Vol 5, Iss 9, Pp 101699- (2024)
Summary: Fibrolamellar carcinoma (FLC) is a rare, lethal, early-onset liver cancer with a critical need for new therapeutics. The primary driver in FLC is the fusion oncoprotein, DNAJ-PKAc, which remains challenging to target therapeutically. It is c
Externí odkaz:
https://doaj.org/article/5fee8c91d0e84541891ec3ad5b4cbeeb
Autor:
Hao Wang, Paul Thomas, Elizabeth M Jaffee, Mark Yarchoan, Jennifer Durham, Brian Ladle, Alex Thompson, Madalena Brancati, Christopher Thoburn, Zeal Kamdar, Marina Baretti, Julie Nauroth, Anna Ferguson, Paige Griffith, Allison Kirk, Neeha Zaidi, Amanda Huff, Won Ho, Mark Furth
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3daf0dc0473d405e8cfc4646bd654963
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/ff784c125ad84e338996659a4d3d34c8
Autor:
Daniel J. Zabransky, Ludmila Danilova, James M. Leatherman, Tamara Y. Lopez‐Vidal, Jessica Sanchez, Soren Charmsaz, Nicole E. Gross, Sarah Shin, Xuan Yuan, Alexei Hernandez, Hongqui Yang, Stephanie Xavier, Daniel Shu, Ali Saeed, Kabeer Munjal, Zeal Kamdar, Luciane T. Kagohara, Elizabeth M. Jaffee, Mark Yarchoan, Won Jin Ho
Publikováno v:
Hepatology
BACKGROUND AND AIMS: The treatment of hepatocellular carcinoma (HCC) has been transformed by the use of immune checkpoint inhibitors. However, most patients with HCC do not benefit from treatment with immunotherapy. There is an urgent need to underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8d8e5bded14d7bc88afdbe64239061
https://europepmc.org/articles/PMC9905363/
https://europepmc.org/articles/PMC9905363/
Autor:
Zeal Kamdar, Tamara Lopez-Vidal, Kathryn Howe, Kabeer Munjal, Ali Saeed, Daniel Zabransky, Daniel Shu, Gabriella Longway, Emma Kartalia, James Leatherman, Aditya Mohan, Pratik Khare, Cissy Zhang, Anne Le, Erika Pearce, Mark Furth, Marina Baretti, Robert Leone, Elizabeth Jaffee, Mark Yarchoan
Publikováno v:
Cancer Research. 83:3679-3679
Fibrolamellar hepatocellular carcinoma (FLC) is a rare and often lethal form of liver cancer that primarily affects children and young adults. A fusion between DNAJB1, a heat shock chaperone protein, and PRKACA, the catalytic domain of protein kinase